Form EFFECT AMICUS THERAPEUTICS,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 |
| Accession Number: | 0001140361-26-016986 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NYC Neuropsychologist Dr. Elyse Bensusan Publishes a Parent-Friendly Guide Demystifying the Process of Getting Services for a Child in NYC
- HCC Healthcare Signs Business Combination Agreement with RF Acquisition Corp III to Pursue Nasdaq Listing
- Canon U.S.A., Inc. Earns the Most Energy Efficient Toner-Based A3 and A4 Brand Awards from Keypoint Intelligence
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
